Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Silexion Therapeutics Corporation SLXNW


Primary Symbol: SLXN

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial... see more

Current News (NDAQ:SLXN)

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer

GlobeNewswire 4 days ago

Silexion Therapeutics to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference

GlobeNewswire 10 days ago

Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer

GlobeNewswire 11 days ago

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 12, 2025

Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer

GlobeNewswire September 30, 2025

Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire September 25, 2025

Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering

GlobeNewswire September 11, 2025

Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration

GlobeNewswire September 11, 2025

Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204

GlobeNewswire September 4, 2025
View More News ››

Opinion & Analysis (NDAQ:SLXN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SLXN)

SLXN.....mini pop on low vol

Possible breakout ....Bi Fat Blue Breakout Line Vols are needed to increase....which they are....$4.20
Iseneschal - October 3, 2025

SLXN....N.H.O.D 1 min before the close ; )

Push it ..... Bing Videos
Iseneschal - October 1, 2025

RE:RE:SLXN....better late than never...so start those drumrolls

Pardon me.....my B.F.B.B. Line is $3.95 Cheers !
Iseneschal - October 1, 2025

RE:SLXN....better late than never...so start those drumrolls

SLXN.....not getting in a tither because it's at the H.O.D.... watching closely ....heres hope that my Big Fat Blue Breakout line at ...
Iseneschal - October 1, 2025

SLXN....better late than never...so start those drumrolls

N.H.O.D .... $3.80
Iseneschal - October 1, 2025

SLXN....On watch !!! N.H.O.D $3.78 low vol

But u have to look at 09/30/25 and the 5 million share volume with the price action.... This has just broke the high of the big vol on 09...
Iseneschal - October 1, 2025
View more Bullboard ››

Nurcapital Capital Pool

Nurcapital Capital Pool

Nurcapital Corporation Ltd. is a Canada-based capital pool company. The Company is engaged in identifying and evaluating ...
View More »